SCHWEIZERISCHES FORSCHUNGSINSTITUT FUR HOCHGEBRIGSKLIMA UND MEDIZIN IN DAVOS
发明人:
Liam O'Mahony,Cezmi A. Akdis,David Michalovich,Edith M. Hessel,James R. Brown,David N. Mayhew,Sorif Uddin
申请号：
US16702285
公开号：
US20200164003A1
申请日:
2019.12.03
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.
